Farshad Guirakhoo
Chief Tech/Sci/R&D Officer at EXPRES2ION BIOTECH HOLDING AB
Profile
Farshad Guirakhoo is the founder of Responsive Bioservices LLC, which was founded in 2017.
He is currently the Chief Scientific Officer at Expres2ion Biotech Holding AB since 2023.
Dr. Guirakhoo's former jobs include Senior Director-External Research & Development at Sanofi Pasteur, Inc. from 2007 to 2012, Senior Director & Head-Virology Research at Acambis, Inc. from 1992 to 2007, Chief Scientific Officer at GeoVax, Inc. from 2015 to 2020, Chief Technology Officer at Vaxess Technologies, Inc. from 2014 to 2015, Chief Scientific Officer at GeoVax Labs, Inc. from 2015 to 2020, and Chief Scientific Officer at Hookipa Biotech AG from 2012 to 2014.
Dr. Guirakhoo's education includes a doctorate from the University of Vienna and a graduate degree from the University of Tehran.
Farshad Guirakhoo active positions
| Companies | Position | Start |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Chief Tech/Sci/R&D Officer | 2023-01-15 |
Former positions of Farshad Guirakhoo
| Companies | Position | End |
|---|---|---|
| GEOVAX LABS, INC. | Chief Tech/Sci/R&D Officer | 2020-08-09 |
GeoVax, Inc.
 GeoVax, Inc. BiotechnologyHealth Technology Part of GeoVax Labs, Inc., GeoVax, Inc. develops biotechnology and vaccines. The company is based in Smyrna, GA. GeoVax was acquired by Dauphin Technology, Inc. on October 03, 2006. The company was founded in 2001 by Harriet Latham Robinson. | Chief Tech/Sci/R&D Officer | 2020-07-31 |
| Responsive Bioservices LLC | Chief Executive Officer | 2020-05-31 |
Vaxess Technologies, Inc.
 Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2015-03-31 |
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Chief Tech/Sci/R&D Officer | 2014-03-31 |
Training of Farshad Guirakhoo
| University of Vienna | Doctorate Degree |
| University of Tehran | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GEOVAX LABS, INC. | Health Technology |
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| VAXXINITY, INC. | Health Technology |
| Private companies | 6 |
|---|---|
GeoVax, Inc.
GeoVax, Inc. BiotechnologyHealth Technology Part of GeoVax Labs, Inc., GeoVax, Inc. develops biotechnology and vaccines. The company is based in Smyrna, GA. GeoVax was acquired by Dauphin Technology, Inc. on October 03, 2006. The company was founded in 2001 by Harriet Latham Robinson. | Health Technology |
Sanofi Pasteur, Inc.
 Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Commercial Services |
| Acambis, Inc. | |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
| Responsive Bioservices LLC |
- Stock Market
- Insiders
- Farshad Guirakhoo